TrialJournal for immunotherapy of cancer2025

Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047.

Meredith M Regan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.